In a new study published recently in the journal Nature, researchers at Vanderbilt University and Vanderbilt Health have created the first growth charts for white matter in the brain over a human ...

A new study has revealed a group of blood proteins that are altered in people who go on to develop multiple sclerosis (MS), in some cases more than a decade before diagnosis. The findings offer hope ...

World MS Day on May 30 unites advocates to push for earlier diagnoses of multiple sclerosis, better medical training, and ...

A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab – a ...

Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve ...

A new study has revealed a group of blood proteins, that are altered in people who go on to develop multiple sclerosis (MS), ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana"), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal ...

Phase 3 trial met its primary endpoint, demonstrating bioequivalent drug exposure between the currently approved BRIUMVI Day 1 and Day 15 initiation dosing and a new single infusion on Day 1 only Safe ...

Halting the insidious accumulation of irreversible disability remains the principal challenge in multiple sclerosis care. Once classified as relapsing (including relapsing-remitting and active ...

Kenneth Iwamasa injected the "Friends" star with a fatal dose of the hallucinogenic drug ketamine in October 2023.

Copyright: © 2026 The Author(s). Published by Elsevier Ltd.